Notably, there was a decrease in ki67 expression in areas of lung tumors from the mice treated with iNOP-7-PLK1 siRNA (Figure 6C), thus providing evidence that systemic administration of iNOP-7-PLK1 siRNA reduced NSCLC cell proliferation in vivo. This evidence concerns the gene PLK1 and non-small cell lung carcinoma.